• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Alterola Biotech Inc
Amplitech Group, Inc. - Common Stock
Cardiovascular Systems, Inc. - Common Stock
Hannover Re Se ADR
Logility Supply Chain Solutions, Inc. - Common Stock
Marker Therapeutics, Inc. - Common Stock
PDF Solutions, Inc. - Common Stock
Performant Healthcare, Inc. - Common Stock
Power REIT (MD) Common Stock
Protagenic Therapeutics, Inc. - Common Stock
Synaptogenix, Inc. - Common Stock
Vanguard Long-Term Corporate Bond ETF
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

6.935 -0.445 (-6.03%)
Delayed Quote Updated: 3:46 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,589,851
Open 7.380
Bid (Size) 6.930 (2,800)
Ask (Size) 6.940 (1,000)
Prev. Close 7.380
Today's Range 6.885 - 7.390
52wk Range 6.230 - 16.44
Shares Outstanding 157,749,490
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Russell 2000 Stock with Solid Fundamentals and 2 We Avoid
October 15, 2026
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
Topics Energy Intellectual Property
News headline image
3 Healthcare Stocks We Find Risky
October 13, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on... 
Via StockStory

Performance

52-Week Range 57.8% below 52-week high
6.935
6.2352W Low 16.4452W High
1 Week 10.5% below 1-week high
7.071W Low 7.751W High

Ocular Therapeutix, Inc. - Common Stock (OCUL) traded between $6.23 and $16.44 over the past 52 weeks and last traded at $6.93, 57.8% below its 52-week high. Over the past week it ranged between $7.07 and $7.75.

Past 12 Months
-8.0%
-31.9%
-24.3%
-21.7%
-41.3%
-41.9%
1W -$0.61
1M -$3.25
3M -$2.23
6M -$1.92
YTD -$4.89
1Y -$5.00

OCUL was -41.9% over the past year, -21.7% over six months, -41.3% year to date, -8.0% in the last week.

12 Months vs Market
OCUL
-41.9%
DIA
+12.0%
SPY
+14.6%
QQQ
+17.6%
IWM
+7.9%

Over the past 12 months OCUL returned -41.9% versus DIA (Dow) +12.0%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.6% and IWM (Russell 2000) +7.9%.

Volume & Liquidity 0.55× 3-mo avg
Today 1,589,851 3-mo avg 2.9M
1W
3.0M
1M
3.8M
3M
2.9M
6M
2.9M
YTD
4.0M
1Y
3.8M

OCUL most recently traded 1,589,851 shares against a 3-month average daily volume of 2.9M.

More News

Read More
News headline image
3 Unprofitable Stocks Walking a Fine Line
October 12, 2026
Via StockStory
News headline image
1 Cash-Burning Stock for Long-Term Investors and 2 Facing Headwinds
October 09, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Stocks Under $10 That Fall Short
October 05, 2026
Via StockStory
News headline image
3 Reasons to Avoid OCUL and 1 Stock to Buy Instead
October 01, 2026
Via StockStory
Topics Stocks
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
September 28, 2026
Via Chartmill
News headline image
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
September 23, 2026
Via StockStory
News headline image
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Success ↗
September 22, 2026
Via MarketBeat
News headline image
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges
September 01, 2026
Via StockStory
News headline image
Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
August 20, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026
August 03, 2026
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
August 03, 2026
Via StockStory
News headline image
3 Russell 2000 Stocks That Concern Us
July 31, 2026
Via StockStory
News headline image
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers
July 26, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment ↗
July 22, 2026
Via MarketBeat
News headline image
3 Cash-Burning Stocks with Open Questions
July 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Small-Cap Stocks with Open Questions
July 08, 2026
Via StockStory
News headline image
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?
June 24, 2026
Via StockStory
Topics Stocks
News headline image
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
June 18, 2026
Via StockStory
Topics Economy
News headline image
Why Ocular Therapeutix (OCUL) Stock Is Up Today
June 17, 2026
Via StockStory
News headline image
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? ↗
June 15, 2026
Via The Motley Fool
News headline image
3 of Wall Street’s Favorite Stocks That Concern Us
June 10, 2026
Via StockStory
News headline image
1 Russell 2000 Stock to Research Further and 2 Facing Headwinds
May 28, 2026
Via StockStory
News headline image
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗
May 26, 2026
Via The Motley Fool
Topics Regulatory Compliance Stocks

Frequently Asked Questions

Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
What is the current price of Ocular Therapeutix, Inc. - Common Stock?
The current price of Ocular Therapeutix, Inc. - Common Stock is 6.935
When was Ocular Therapeutix, Inc. - Common Stock last traded?
The last trade of Ocular Therapeutix, Inc. - Common Stock was at 10/16/26 03:46 PM ET
What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.09B
How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
Ocular Therapeutix, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap